Vastarel MR Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Trimetazidine diHCl

Indications/Uses

Add-on therapy for the symptomatic treatment of patients w/ stable angina pectoris who are inadequately controlled by or intolerant to 1st-line antianginal therapies.

Dosage/Direction for Use

35 mg bd (ie, once in the morning & once in the evening during meal). Patient w/ moderate renal impairment (CrCl 30-60 mL/min) & elderly 35 mg in the morning during breakfast.

Administration

Should be taken with food.

Contraindications

Hypersensitivity. Parkinson disease, parkinsonian symptoms, tremors, restless leg syndrome & other related movement disorders. Severe renal impairment (CrCl <30 mL/min).

MIMS Class

Anti-Anginal Drugs

ATC Classification

C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.

Regulatory Classification

POM

Presentation/Packing

Form

Vastarel MR MR-FC tab 35 mg

Packing/Price

1's

Vastarel MR

trimetazidine

Manufacturer:

Kotra Pharma